6 Specialists Offering Clinical Trial Access for Advanced Breast Cancer in 2026
Standard treatment options are running thin, and the next line of chemotherapy promises smaller gains for the same toxicity.
A trial built around your exact mutation might exist right now, recruiting at a hospital a few hours away, but nothing about the system makes that easy to find. There is no single directory of open trials that a patient can browse, no waiting room notice board, no obvious next call to make. Family members spend nights searching forums and closed Facebook groups, collecting names of doctors and hospitals with no way to tell which leads are real.
The truth is less mysterious than it feels. A small, specific group of people and platforms in India control that access, coordinating networks, hospital navigator teams, genomic testing companies, and a couple of registries anyone can search for free. Once you know who they are and what each one actually does, the search stops being a guessing game.
This article names six, what each one actually does, and how to reach them.
Key Takeaways
Clinical trial access for advanced breast cancer in India runs through a specific chain: a treating oncologist, a navigator or platform that checks the wider network, and often a genomic test that opens up biomarker matched trials.
The six resources below cover a coordinating network, a hospital trial unit, two second opinion services, a genomic matching company, a financial support organization, and two free registries you can search yourself.
Two of these, ClinicalTrials.gov and CTRI, cost nothing and can be checked before your first appointment, so you can walk in already holding specific protocol numbers.
Your Treating Oncologist Comes First
Before any of the names below matter, your treating oncologist is the first stop. Every pathway into a trial, whether through a coordinating network, a genomic test, or a second opinion, starts with someone reviewing your pathology, staging, and prior treatment lines.
Many patients pair that first opinion with an independent second read, particularly one focused specifically on breast cancer rather than oncology in general, before deciding on the next step. What follows is what happens once that conversation has already taken place, and who else can widen the search from there.
How the Six Specialists and Programs Compare
Specialist or Program | Type | Primary Function | Cost to Patient | Best Suited For |
National Cancer Grid Clinical Trial Network | Coordinating network | Links member hospitals into multi center trials, runs virtual tumor boards | Free to access; treatment costs vary by hospital | Patients at any NCG member hospital |
ACTREC / Tata Memorial Navigator Team | Hospital trial unit | Pre screens patients, manages enrollment logistics for Phase I to IV trials | No cost for navigation; trial drug typically sponsor covered | Patients treating at ACTREC or Tata Memorial |
Navya | Virtual second opinion platform | Coordinates remote multidisciplinary tumor board review | Paid consultation fee | Patients unable to travel to a flagship center |
Dr Bharat Patodiya | Independent specialist | Second opinion on breast cancer diagnosis and treatment plan | Consultation fee; financial assistance referrals available | Patients wanting an independent, breast cancer specific opinion |
4baseCare | Genomic testing and AI platform | Genomic profiling paired with trial matching through a molecular tumor board | Cost of genomic test, varies by panel | Patients with or seeking biomarker testing |
ClinicalTrials.gov and CTRI | Public registries | Self service search for recruiting trials | Free | Anyone doing initial research before a consult |
1. National Cancer Grid Clinical Trial Network
National Cancer Grid coordinates more than 300 cancer centers across India and runs a dedicated Clinical Trial Network with funding from the Biotechnology Industry Research Assistance Council. This network exists specifically to run trials across multiple centers at once, so a protocol open at one member hospital can often be reached through another.
Runs a twice weekly Virtual Tumor Board where oncologists across member centers review complex cases together
Coordinates an 11 center clinical trial network anchored by Tata Memorial Hospital, built specifically for multi centric oncology trials
Sets uniform treatment guidelines used across its member network, guidelines that government schemes like Ayushman Bharat have adopted, so a trial referral from one NCG center is read the same way at another
Best for: Patients already being treated at, or able to reach, any NCG member hospital who want their case checked against the wider network rather than just one hospital's own trial list.
2. Clinical Trial Navigator Team at Tata Memorial Centre / ACTREC
The Department of Medical Oncology at ACTREC, part of Tata Memorial Centre, sees more than 300 patients a day and runs a dedicated navigator team behind its trial portfolio. This team does not decide who qualifies for a trial. It does the groundwork that gets your file in front of the people who do.
Pre screens incoming patients against globally sponsored and investigator initiated studies spanning Phase I through IV
Manages the practical steps of enrollment: confirming age and disease criteria, collating prior treatment lines, and scheduling required screening scans or biopsies
Tracks genomic inclusion windows for basket trials like ComboMATCH, where eligibility depends on a specific mutation rather than cancer type alone
Best for: Patients who have decided ACTREC or Tata Memorial is where they want to be treated and need someone to handle the administrative matching once they arrive.
3. Navya
Navya is a clinical informatics platform built with Tata Memorial Centre and the National Cancer Grid to bring a full tumor board opinion to patients who cannot travel to get one. You upload your reports, a patient advocate contacts you, and a virtual multidisciplinary panel reviews your case.
Draws on more than 300 senior oncologists across NCG member centers for each opinion, not just one doctor's read of your file
Delivers a treatment plan within 1 to 3 days rather than the weeks a series of in person consults can take
Has published concordance data specifically in breast cancer treatment decisions, with its recommendations matching in-person tumor board outcomes in the large majority of reviewed cases
Best for: Patients in smaller cities or outside India who want a second opinion informed by the same network of experts as a flagship cancer center, without the travel.
4. Dr Bharat Patodiya
Dr Bharat Patodiya is a Hyderabad based medical oncologist with a certificate of competence in breast cancer from the University of Ulm, Germany, and direct participation in international consensus conferences on breast cancer treatment, including the St Gallen and Advanced Breast Cancer meetings.
Reviews treatment plans and pathology already underway elsewhere; patients have specifically sought him out for a second opinion on care started at another center
Completed an industry Phase 4 clinical trial preceptorship, giving him direct exposure to how trial protocols and eligibility criteria are structured
Has a track record of connecting patients to charitable trusts for financial support when cost, not diagnosis, is the barrier to treatment
Best for: Patients or families who already have a pathology report or an ongoing treatment plan and want an independent, breast cancer focused second read before their next decision.
5. 4baseCare
4baseCare is a Bengaluru based precision oncology company that runs comprehensive genomic profiling and pairs it with an AI platform built to support treatment and trial decisions. Where a pathology report tells you what type of cancer you have, this is the layer that tells you which mutations might make you eligible for a specific drug or trial.
Offers tissue, liquid biopsy, and combined dual source genomic testing built to surface actionable mutations, including HRD and germline results relevant to PARP inhibitor eligibility
Runs a molecular tumor board service that folds genomic results into a single case review with clinicians
Its OncoTwin platform includes a dedicated clinical trial optimization function built to weigh patient genomic profiles against trial eligibility criteria
Best for: Patients who already have, or are about to get, genomic or biomarker testing done and want that data actively checked against trial criteria rather than filed away.
6. ClinicalTrials.gov and CTRI
ClinicalTrials.gov and India's Clinical Trials Registry (CTRI) are the two databases you can search yourself, before you have seen a specialist at all.
ClinicalTrials.gov lets you filter by condition, country, and recruitment status, and surfaces global protocols such as biomarker specific studies for HR positive, HER2 negative breast cancer with a PIK3CA mutation. It is worth checking each listing's actual enrollment sites rather than assuming India access, since many global trials do not list an Indian site
CTRI, maintained under India's drug regulator at ctri.nic.in, covers investigator initiated studies at Regional Cancer Centres that sometimes do not appear on the global database at all
Both are free and update in real time, so checking them before your appointment turns a general question into a specific one your oncologist can act on
Best for: Anyone who wants to walk into their first oncology consult already holding a short list of protocol numbers instead of a blank page.
How to Search the Trial Registries Yourself
You do not need to wait for an appointment to start looking. Both registries are free, public, and update as new trials open, so a few minutes of searching can turn a general question into a specific one.
Search ClinicalTrials.gov for your condition, country, and recruitment status, and note the NCT numbers
Search CTRI for the same condition, capturing any additional protocol identifiers
Check whether your target hospital maintains its own studies list. Some protocols only appear there, not on either registry
Save the NCT numbers and a one paragraph summary of each matching protocol
Bring these to your oncologist so the conversation starts with specific protocols, not a general question
Conclusion
None of the six names above replace the file you bring with you. Before your next appointment, whichever of these you decide to contact, put together:
Your complete pathology report, including ER, PR, and HER2 status
Any genomic or biomarker testing already done, or a clear note that none has been done yet
Copies of your imaging, especially anything showing new or growing sites of disease
A written timeline of every treatment line so far, with dates and the reason each one stopped
Your current performance status, even a rough note on what you can and cannot do day to day, since updated guidance is pushing trials to include a wider range of patients on this measure than before
A specialist can only match you to a trial as fast as this file lets them. Walking in with it complete, rather than promising to send it later, is often the single biggest thing that shortens the distance between a diagnosis and a seat in a trial.
If your case has already been through one round of treatment elsewhere, it is worth getting that file read again by someone whose practice is built specifically around breast cancer rather than oncology broadly. A second, subtype specific read sometimes surfaces an option the first review did not have reason to look for.
Does health insurance in India cover any part of a clinical trial?
Frequently Asked Questions
What types of specialists coordinate clinical trial access for advanced breast cancer patients in India?
The pathway is coordinated by several dedicated roles and teams:
Medical oncologists at NCG centers: act as the primary gateway for trial access.
Clinical trial navigators at high-volume research centers: manage pre-screening and enrollment logistics.
Multidisciplinary tumor boards: formally validate patient eligibility.
Financial navigators or NGO coordinators: handle the ancillary cost planning.
How does a patient find and enroll in a clinical trial for metastatic breast cancer?
To begin the enrollment process, take these steps:
Search ClinicalTrials.gov and the CTRI (ctri.nic.in) filtering for 'advanced breast cancer' and 'recruiting' studies in India.
Bring the relevant NCT numbers to a medical oncologist at an NCG-affiliated center.
The oncologist confirms biomarker and performance status eligibility.
The center's navigator then manages the formal enrollment process.
What is the role of a multidisciplinary tumor board in determining trial eligibility for advanced breast cancer?
The tumor board integrates pathology and radiology findings with molecular profiling to confirm protocol-specific inclusion and exclusion criteria. It rules out therapeutic conflicts between concurrent palliative medications and the investigational agent, and formally validates that symptom management will not confound the trial's endpoints.
Which institutions in India are known for offering clinical trials for advanced breast cancer?
Tata Memorial Centre and ACTREC run globally sponsored Phase I to IV trials and manage over 300 daily patients. Regional Cancer Centres operate Phase I units and patient access programs under CDSCO oversight. The Clinical Research Secretariat at Tata Memorial maintains a specific breast cancer trial registry.
What are the costs and financial support options for participating in a breast cancer clinical trial?
Industry sponsors typically cover the investigational drug and protocol-mandated tests. Patients bear travel, lodging, caregiver costs, and standard-of-care components outside the protocol. Hospital social workers, charitable trusts within the institution, and NGOs like MENCAN provide stipends and financial assistance for ancillary expenses.
How does integrative or palliative care work alongside clinical trial participation for advanced breast cancer?
Palliative care is not automatically excluded. The tumor board formally reviews concurrent symptom management medications and interventions to confirm no drug-drug interactions with the investigational agent exist and that organ function thresholds are maintained. Symptom control runs in parallel with the protocol under multidisciplinary oversight.
Sources
Best Breast Cancer Specialist (Oncologist) | Dr. Bharat Patodiya - www.drbharatpatodiya.com
[PDF] NCTN Breast Cancer Trials Portfolio (Open as of 5/15/2026) - dctd.cancer.gov
A Retrospective Analysis of Clinical Trial Accrual of Patients Presented in a Multidisciplinary Tumor Board at a Tertiary Health Care Center and Associated Barriers - PMC - pmc.ncbi.nlm.nih.gov
Advanced Centre for Treatment Research & Education in Cancer | Medical Oncology - actrec.gov.in
Study Details | NCT06257888 | A Prospective Cohort With Patient Navigation as an Intervention for Breast Cancer Patients | ClinicalTrials.gov - clinicaltrials.gov
Cancer Clinical Trial Eligibility Criteria: Performance Status - www.hhs.gov
clinical trial centre - Tata Memorial Hospital - tmc.gov.in
Comments